Fig. 1

Comparison of prevalence of clinicopathological features according to mutation status. Results from Table 2 were visualized if there were significant differences between groups. A Female; B never-smoker; C > 5% lepidic component; D > 5% solid component; E solid predominance; F IASLC grade 3; G lymphatic invasion; H vascular invasion. **P < 0.01; *P < 0.05; N.S., not significant. Abbreviations: IASLC, International Association for the Study of Lung Cancer